- Search jobs
- hamilton on
- oncology nurse navigator
Oncology nurse navigator Jobs in Hamilton on
- Promoted
Laboratory Animal Technician
Fusion PharmaceuticalsHamilton, Ontario, Canadanurse aide
Alert Best Nursing and Home CareHamilton, ON, CARegistered Nurse
Hamilton Health SciencesHamilton, OntarioObstetrics Registered Nurse
Elite365Hamilton, ON, CARegistered Practical Nurse
McMaster UniversityHamilton, Ontario, CAFirst Nations / Metis / Inuit Candidates - Housing Support Program Navigator
Hamilton Regional Indian CentreHamilton, ON- Promoted
Travel Registered Nurse
World Health Labs USA IncHamilton, ON, CanadaCommunity Health Navigator- Assisted Living
Good Shepherd CentresHamilton, ON, CANRegistered Nurse (RN) - Hamilton
RhynoCareHamilton, Ontario, CanadaClient Care Navigator
Vision Loss Rehabilitation CanadaHamilton, Ontario, Canada- Promoted
Registered Practical Nurse (RPN) - LTC
Schlegel VillagesHamilton, ON, CANRegistered Nurse ML FT evenings
City of HamiltonHamilton, ON, CARegistered Practical Nurse (Idlewyld Manor)
Thrive Group CanadaHamilton, OntarioResearch & Development Laboratory Manager
Fusion Pharmaceuticals US, Inc.Hamilton, ONOB Nurse needed in California
KYND InternationalHamilton, ON, CARegistered Practical Nurse
St. Joseph HomecareHamilton, ON, CARegistered Nurse - ICU
Carecor Health Services Ltd.Hamilton, ONLaboratory Animal Technician
Fusion PharmaceuticalsHamilton, Ontario, Canada- Full-time
Fusion Pharmaceuticals, a member of the AstraZeneca Group , is a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines. Fusion connects alpha particle emitting isotopes to various targeting molecules to selectively deliver the alpha emitting payloads to tumors. Fusion’s clinical portfolio includes : FPI-2265 targeting prostate specific membrane antigen (PSMA) for metastatic castration resistant prostate cancer currently in a Phase 2 trial; FPI-1434 targeting insulin-like growth factor 1 receptor currently in a Phase 1 trial;FPI-2059, a small molecule targeting neurotensin receptor 1 (NTSR1), currently in a Phase 1 trial; and FPI-2068, a bispecific IgG-based EGFR-cMET targeted radioconjugate currently in a Phase 1 trial. In addition, Fusion is pursuing combination programs between RCs and DNA Damage Response Inhibitors (DDRis) and immune-oncology agents. Fusion has a fully operational Good Manufacturing Practice (GMP) compliant state-of-the-art radiopharmaceutical manufacturing facility to meet supply demand for Fusion's growing pipeline of RCs.
Fusion is seeking outstanding applicants for a Laboratory Animal Technician to support a broad range of preclinical drug development activities. This position is lab-based, and located in Hamilton, Ontario, Canada.
Responsibilities (including, but not limited to) :
- Conduct and report on therapeutic efficacy and biodistribution studies of radiopharmaceuticals using rodent models of cancer (or other disease indications of interest)
- Maintain rodent cohorts (including husbandry, tumor measurements, tissue sample collection, and endpoint monitoring), establish tumour xenografts, and administer test articles to rodents by various routes including injection and oral gavage
- Perform mammalian cell culture in support of biology group activities
- Document experimental procedures and results in an electronic notebook system
- Assist in the maintenance of laboratories, animal facilities, and laboratory equipment
- Maintain laboratory records (SOPs, SDS, chemical, radioisotope, biohazard, cell bank)
- Other duties as required
Qualifications :
All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran.